Recent Posts
- Ultragenyx Provides Update on Stage 1 Cohorts in Phase 1/2/3 Cyprus2+ Study for Wilson Disease with AAV9 Gene Therapy
- World-First CAR-T Therapy Using Donor Cells Sends Autoimmune Diseases into Remission
- Analysis of Adeno-Associated Virus Tropism in Mice: A Comprehensive Survey of AAV Serotypes
- Advances in AAV-SB Transposon Hybrid Systems for Liver-Targeted Gene Therapies
- Eli Lilly to Invest $4.5 Billion in New Drug Manufacturing and Research Facility
AAV One-stop Solution
Tags
AAV2
AAV5
AAV based gene therapy
AAV Capsid
ALS
Alzheimer’s Disease
brain vasculature
cancer
CAR-T
Cell Therapy
COVID-19
COVID vaccine
CRISPR
CRISPR/Cas
Drug Development
dystrophin
eye disease
FDA
gene editing
gene therapy
genetic engineering
genome editing
GMP plasmid
hearing
heart disease
hemophilia
Hemophilia B
hepatitis research
HIV
immunotherapy
liver cancer
mRNA
Neurodegenerative Diseases
Orphan Drug
Parkinson
rare disease
Retinoschisis
RNA
RNAi therapeutics
RNA vaccines
SARS-CoV-2
Sickle Cell Disease
SMA Treatment
thyroid
zolgensma